ProShare Advisors’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $123K | Sell |
10,028
-671
| -6% | -$8.21K | ﹤0.01% | 1833 |
|
|
2025
Q1 | $153K | Sell |
10,699
-2,994
| -22% | -$42.9K | ﹤0.01% | 1755 |
|
|
2024
Q4 | $218K | Buy |
13,693
+4,210
| +44% | +$67K | ﹤0.01% | 1845 |
|
|
2024
Q3 | $228K | Buy |
+9,483
| New | +$228K | ﹤0.01% | 1655 |
|
|
2022
Q2 | – | Sell |
-10,703
| Closed | -$357K | – | 1819 |
|
|
2022
Q1 | $357K | Sell |
10,703
-1,321
| -11% | -$44.1K | ﹤0.01% | 1508 |
|
|
2021
Q4 | $416K | Buy |
12,024
+4,614
| +62% | +$160K | ﹤0.01% | 1581 |
|
|
2021
Q3 | $231K | Sell |
7,410
-6,382
| -46% | -$199K | ﹤0.01% | 1713 |
|
|
2021
Q2 | $502K | Sell |
13,792
-2,658
| -16% | -$96.7K | ﹤0.01% | 1540 |
|
|
2021
Q1 | $720K | Buy |
16,450
+2,152
| +15% | +$94.2K | ﹤0.01% | 1196 |
|
|
2020
Q4 | $656K | Buy |
14,298
+5,234
| +58% | +$240K | ﹤0.01% | 1096 |
|
|
2020
Q3 | $301K | Sell |
9,064
-1,339
| -13% | -$44.5K | ﹤0.01% | 1173 |
|
|
2020
Q2 | $306K | Buy |
+10,403
| New | +$306K | ﹤0.01% | 1216 |
|
|
2020
Q1 | – | Sell |
-11,620
| Closed | -$392K | – | 1202 |
|
|
2019
Q4 | $392K | Buy |
11,620
+1,521
| +15% | +$51.3K | ﹤0.01% | 1195 |
|
|
2019
Q3 | $378K | Buy |
10,099
+200
| +2% | +$7.49K | ﹤0.01% | 1099 |
|
|
2019
Q2 | $432K | Sell |
9,899
-1,030
| -9% | -$45K | ﹤0.01% | 1069 |
|
|
2019
Q1 | $466K | Buy |
10,929
+1,450
| +15% | +$61.8K | ﹤0.01% | 1038 |
|
|
2018
Q4 | $425K | Sell |
9,479
-1,830
| -16% | -$82.1K | ﹤0.01% | 1006 |
|
|
2018
Q3 | $775K | Buy |
11,309
+10
| +0.1% | +$685 | 0.01% | 932 |
|
|
2018
Q2 | $647K | Buy |
11,299
+156
| +1% | +$8.93K | ﹤0.01% | 1004 |
|
|
2018
Q1 | $513K | Sell |
11,143
-1,103
| -9% | -$50.8K | ﹤0.01% | 1084 |
|
|
2017
Q4 | $566K | Buy |
12,246
+4,932
| +67% | +$228K | ﹤0.01% | 1068 |
|
|
2017
Q3 | $329K | Sell |
7,314
-1,023
| -12% | -$46K | ﹤0.01% | 1105 |
|
|
2017
Q2 | $327K | Sell |
8,337
-1,907
| -19% | -$74.8K | ﹤0.01% | 1124 |
|
|
2017
Q1 | $390K | Sell |
10,244
-2,635
| -20% | -$100K | ﹤0.01% | 1110 |
|
|
2016
Q4 | $476K | Buy |
12,879
+3,735
| +41% | +$138K | 0.01% | 1101 |
|
|
2016
Q3 | $317K | Sell |
9,144
-2,213
| -19% | -$76.7K | ﹤0.01% | 1130 |
|
|
2016
Q2 | $369K | Buy |
11,357
+70
| +0.6% | +$2.27K | ﹤0.01% | 1099 |
|
|
2016
Q1 | $324K | Sell |
11,287
-1,529
| -12% | -$43.9K | ﹤0.01% | 1176 |
|
|
2015
Q4 | $428K | Buy |
12,816
+2,917
| +29% | +$97.4K | 0.01% | 1113 |
|
|
2015
Q3 | $282K | Sell |
9,899
-4,366
| -31% | -$124K | ﹤0.01% | 1171 |
|
|
2015
Q2 | $578K | Buy |
14,265
+5,596
| +65% | +$227K | 0.01% | 1036 |
|
|
2015
Q1 | $427K | Sell |
8,669
-1,022
| -11% | -$50.3K | 0.01% | 1263 |
|
|
2014
Q4 | $441K | Buy |
+9,691
| New | +$441K | 0.01% | 1264 |
|